# Simultaneous Blood Flow Measurement and Dermoscopy of Skin Lesions Using Dual-Mode Dermascope

## Abstract

Dermascopes are commonly utilized for the qualitative visual inspection of skin lesions. While automated image processing techniques and varied illumination strategies have been used to aid in structural analysis of lesions, robust quantification of functional information is largely unknown. To address this knowledge gap, we have developed a compact, handheld dermascope that enables real-time blood flow measurements of skin during conventional visual inspection. In-vitro characterization demonstrated that the dermascope is capable of quantifying changes in flow across a physiologically relevant range even when used in a handheld manner with clinic lighting and dermascope LEDs on. In a small pilot clinical study, we demonstrated the dermascope’s ability to detect flow differences between two distinct lesion types.

## Introduction

Dermoscopy, the use of a handheld device with a magnifying lens and light source, is commonly used in the field of dermatology to aid in the visual inspection of suspicious skin lesions. Dermoscopy has been shown to improve diagnostic accuracy of melanocytic and nonmelanocytic pigmented lesions compared to the unaided eye, and can specifically aid the diagnosis of melanoma, basal cell carcinoma, and squamous cell carcinoma1,2,3. Timely and accurate diagnosis of such lesions is critical due largely to their particularly high incidence rate and potential morbidity. Non-melanoma skin cancer is the most common cancer in the US with an estimated 3.5 million cases each year, and although mortality rates are relatively low, it represents a significant burden to the healthcare system4,5. Melanoma has an estimated five-year mortality rate as high as 23%6 depending on lesion stage. Although dermoscopy aids inspection of lesions, the subjectivity and difficulty in interpreting magnified lesion images commonly necessitates biopsy of suspicious lesions for histopathological inspection, and this practice is still viewed as a diagnostic gold standard.

To help overcome the reliance on biopsies, diagnostic methodologies which attempt to standardize the analysis of dermascope images have been used to assess pigmented lesions. These include the ABCD rule and the seven-point check list, which rely on color and structural information to characterize lesions7,8,9. Although these tools offer a degree of quantification and objectivity to lesion assessment, their accuracy and general applicability has been questioned10,11. Several commercial dermascopes have been developed to aid in objective and quantitative assessment of acquired images, including MoleMax and SolarScan. These devices use an embedded camera to acquire images and software to aid in image analysis12.

Dermascopes with functionality beyond reliance on simple white-light illumination have also been explored to aid in diagnosis. Most commonly, cross-polarized illumination dermascopes have been used to reject superficially reflected and scattered light and thus aid in visualization of subsurface features13. To assist in the visualization of tissue structures within lesions that exhibit varying spectral characteristics (predominantly absorption), multispectral dermascopes have also been investigated. These devices inspect a region using different spectral bandwidths of light that can improve visualization of lesion texture, blood vessel morphology, and melanin location2,14,15,16,17. Commercial embodiments include the SIAscope and MelaFind, which use multispectral information to aid in identifying morphological features18,19.

Despite these advancements in dermoscopy, the techniques and devices described above, all rely solely on structural information to aid in diagnosis. Functional information, such as tissue perfusion, may supplement this structural information to provide a more robust characterization or diagnosis of inspected lesions. For example, it is well known that tumor progression is closely accompanied by angiogenesis as additional blood flow is needed to meet the metabolic demands of neoplastic tissue20,21. It has been shown histologically that the density of microvasculature is increased significantly in squamous cell and basal cell carcinomas relative to normal skin22. This finding has been further supported using laser Doppler perfusion imaging, which has demonstrated that blood flow in skin tumors is significantly greater than the surrounding skin and that varying degrees of skin blood flow may aid in differentiating tumor type23,24.

To that end, we have developed a handheld dermascope that enables the user to perform standard magnified analysis of skin lesions simultaneously with skin blood flow measurements. This was achieved by integrating a compact laser speckle contrast imaging (LSCI) system into a custom-built dermascope (called the LSCI-dermascope). While LSCI is a flexible technique for quantifying cutaneous blood flow, clinical adoption is hindered by the fact that commercial LSCI systems are relatively large and bulky, do not provide simple registration of inspected lesions with collected blood flow maps, and suffer from measurement artifact due to movement25,26. We have designed the LSCI-dermascope to overcome these limitations and facilitate the practical integration of perfusion assessment into a typical dermatology workflow.

## Results

### Quantification of LED/room light interference on LSCI measurements

To determine whether room light and the white LED lights used for visual inspection of the skin would interfere with laser speckle contrast imaging (LSCI) measurements during LSCI-dermascope use, the average speckle contrast in a static tissue phantom was measured with and without these light sources on. The results can be seen in Fig. 1. The average speckle contrast did not vary significantly between any of the measurements (p > 0.05), demonstrating that neither room lights nor illumination LEDs significantly affected LSCI measurements.

### Quantification of measurement error due to user motion

LSCI measurements are prone to artifact due to user movement. To quantify whether user movement significantly altered LSCI measurements performed using the LSCI-dermascope, average speckle contrast was measured from a static tissue phantom with the LSCI-dermascope either mounted or used handheld. The results can be seen in Fig. 2. The average speckle contrast did not vary significantly between mounted versus handheld measurements (p > 0.05), demonstrating that user movement during handheld use of the LSCI-dermascope did not significantly affect measurements relative to mounted use. Error bars represent standard deviation between measurements.

### Characterization of LSCI-dermascope measurements in a blood flow phantom

To characterize the response of LSCI-dermascope to varying degrees of simulated blood flow, LSCI measurements were acquired from a tissue phantom with an embedded tube through which Intralipid was flowed at known rates. A diagram of the measurement setup and plot of the average speckle contrast in a dynamic region above the tube and static region away from the tube for each volumetric flow are shown in Fig. 3. The decrease in speckle contrast relative to increasing volumetric flow in the dynamic region follows the expected exponential trend. The fact that the speckle contrast did not approach 0 at higher flow rates is likely due to the signal contribution from static scatterers around the embedded tube whose speckle contrast is not reduced by increasing flow rates within the tube. The speckle contrast in the static region did not significantly change as the volumetric flow rate was adjusted (p < 0.05). Error bars represent standard deviation between measurements.

### In vivo validation of LSCI-dermascope

The ability of the LSCI-dermascope to quantify differences in blood flow between different skin lesions was validated by acquiring LSCI measurements from lesions expected to have increased blood flow relative to the surrounding tissue (cherry angiomas, n = 13), and from skin lesions not expected to have increased blood flow relative to the surrounding tissue (solar lentigos, n = 10). Representative color images of each lesion type along with a corresponding blood flow map are shown in Fig. 4. Average blood flow within each lesion type relative to the surrounding skin is also shown in Fig. 4. The ratio of blood flow within cherry angiomas relative to surrounding skin was significantly higher than that of solar lentigos (p < 0.05). LSCI-dermascope measurements took approximately 10–15 seconds per lesion.

## Discussion

Dermascopes are one of the most frequently used tools by dermatologist for the inspection of suspicious skin lesions. However, while improvements to dermascopes over the past several decades have offered additional structural information, little to no functional information can be measured. Since abnormalities in functional tissue properties such as blood flow often accompany skin pathologies, the inability to measure such properties represents a potentially significant gap in diagnostic or prognostic capability. LSCI has been used extensively to measure tissue blood flow; however, its practical use in the dermatology clinic is limited by the fact that most measurement systems are relatively large and bulky, do not provide simple co-registration of inspected lesions with collected blood flow, and suffer from measurement artifact due to movement. We have described a LSCI-dermascope which addresses each of these limitations.

To address the size limitation of conventional LSCI systems, we utilized compact laser illumination and imaging hardware to create a device that is comparably sized to a conventional dermascope and equally simple to use. To address the difficulty in registering LSCI flow maps with visually inspected lesions, the LSCI-dermascope spectrally separates laser illumination from white-light illumination. We demonstrated that dermoscopy, even with the room lights on, could be performed simultaneously with LSCI measurements without significant effects on the collected data. To address the potential for measurement errors due to motion, we have developed a probe which uses minimal but direct contact with the subject to help stabilize the device. This resulted in LSCI measurements that could be acquired by hand without significant motion artifact.

Beyond the limitations above, we additionally addressed the relative nature of LSCI measurements by presenting blood flow information from measured lesions relative to that in the surrounding tissue. Acquiring LSCI data from both regions is relatively simple, because simultaneous imaging with white light streamlines identification of lesions and their borders. By utilizing the surrounding tissue of an inspected lesion as an internal control, factors that can affect LSCI measurements but unrelated solely to lesion blood flow can be minimized or eliminated. These include changes in laser coherence, imaging angle, tissue curvature, room temperature, subject position, and others25,26,27,28,29. As such, utilizing an internal control for measurements is potentially useful for collecting data that can be compared from subject to subject.

Finally, in a small pilot clinical study, we demonstrated the ability of the LSCI-dermascope to measure significant blood flow differences between two distinct skin lesion types: cherry angiomas and solar lentigos. This result is consistent with expected results. Cherry angiomas are papules with an abnormally high density of superficial capillaries that are expected to exhibit increased perfusion relative to normal skin. Alternatively, solar lentigos are macules of the epidermis characterized by increased basal layer pigmentation without alterations in the skin microvasculature and therefore are not expected to exhibit altered perfusion relative to the surrounding skin30,31,32,33,34.

In summary, we have presented a novel dermascope that is capable of providing functional tissue information in combination with standard structural information. By addressing many of the shortcomings associated with typical LSCI measurements, the LSCI-dermascope enables relatively quick and simple measurements perfusion measurements from lesions. Very little additional time is required for LSCI-dermascope measurements compared to conventional dermoscopy, facilitating practical use in the clinic. Future study will entail determining whether lesion blood flow information provided by the LSCI-dermascope can be used adjunctively with standard lesion diagnostic assessment to improve diagnostic accuracy without necessitating tissue biopsy.

## Methods

### Construction of LSCI-dermascope

A photograph of the LSCI-dermascope and a diagram illustrating the internal components is shown in Fig. 5.

Conventional dermascope functionality was performed by illuminating the tissue under inspection with four white LEDs (SMLP12WBC7W1, Rohm Semiconductor, Kyoto, Japan) wired in series with a 20 mA current limiter (NSI45020, ON Semiconductor, Phoenix, Arizona) and mounted inside of a light diffusing cone that was placed in direct contact with the skin during imaging. LED light remitted from the tissue entered a 50:50 beam splitter (CM1-BS013, Thorlabs Inc., Newton, New Jersey) that directed approximately half of the light into the handle of the LSCI-dermascope and approximately half of the light toward the eye of the user. LED light directed into the handle was collimated using a 35 mm focal length lens (59–872, Edmund Optics Inc., Barrington, New Jersey) and then attenuated using a 780 nm longpass dielectric filter (ET780lp, Chroma Inc., Bellows Falls, Vermont). LED light directed toward the eye of the user was magnified using a 60 mm focal length lens (LB1596-A, Thorlabs Inc., Newton, New Jersey) and then passed through a 700 nm shortpass filter (FESH0700, Thorlabs Inc., Newton, New Jersey).

To perform LSCI simultaneously with conventional dermascope imaging, a 50 mW 785 nm laser diode (785MD-3-0610, LaserLands, Spalstraat, Netherlands) was affixed to the side of the diffusing cone. The diffusing cone was machined from an acetal polymer whose optically scattering properties created a more homogenous illumination field for LSCI measurements than would be achieved by illuminating the tissue directly by the laser diode35. Laser light remitted from the same region of tissue being imaged during conventional dermascope measurements was also separated using the 50:50 beam splitter. Laser light directed toward the eye of the operator was attenuated via the shortpass filter. Laser light directed toward the handle of the device was collimated using a 35 mm focal lens and then directed through a 780 nm longpass filter and into a 35 mm camera lens mounted to a CMOS camera (FireFly MV, 6.0 µm pixel size, FLIR Integrated Imaging Solutions, Inc., BC, Canada). The 3.3 V power supply on the CMOS camera was used to power both the LEDs and laser diode during imaging. The camera lens was set to an f/# of 8, as this aperture enabled sampling of the speckle pattern which satisfied the Nyquist criterion36. The resulting dual-mode imaging system enabled acquisition of co-registered visual and camera-based (LSCI) images.

### Flow measurements using the LSCI-dermascope

Quantitative blood flow maps were acquired using LSCI, which is an optical technique that uses a coherent light source and a CMOS/CCD camera to create wide-field quantitative maps of tissue blood flow37,38,39,40,41. The technique is based on the principle of quantifying the spatiotemporal changes in the speckle pattern that result from the constructive and destructive interference of the laser light used to illuminate the tissue. Movement of blood within the tissue causes changes in the speckle pattern and blurring in collected images, which can be quantified using a metric called speckle contrast to create full-field maps of tissue blood flow. Speckle contrast, K, is conventionally computed as:

$$K=\frac{\sigma }{ < I > }$$
(1)

where σ and <I> represent the standard deviation and average number of the pixel counts in a local neighborhood of pixels. LSCI images acquired with the LSCI-dermascope were acquired at a rate of 30 frames per second and at a pixel resolution of 640 × 480. Speckle contrast maps were computed from raw images using a 7 × 7 spatial sliding window algorithm that implemented Equation (1). In some instances, speckle contrast maps were converted to speckle flow index (SFI) maps because SFI has been shown to correlate linearly with blood flow and therefore offers a more intuitive representation of flow within an object42,43. SFI was computed as:

$$SFI=\frac{1}{2T{K}^{2}}$$
(2)

where T represents the exposure time of the camera using during image acquisition. In all experiments, an exposure time of 5 ms was used44. Image acquisition and processing was performed using custom software written in MATLAB.

### Quantification of LED/room light interference on LSCI measurements

The presence of LED or room light within images collected for LSCI measurements can potentially introduce measurement error. Room light which travels through the lens of the LSCI-dermascope and white LED light projected directly onto the region of interest are relatively broadband sources incoherent light, which if not adequately filtered from the signal detected by the camera system, will result in an artificial decrease in speckle contrast. To quantify this effect on the LSCI-dermascope, LSCI measurements were acquired from a tissue-simulating phantom with and without the LEDs and fluorescent room lights turned on. The phantom was fabricated from polydimethylsiloxane with titanium dioxide added to achieve a reduced scattering coefficient of 1 mm−1 at 785 nm45,46. For each measurement condition (LEDs and room lights on/off), 10 measurements were acquired and averaged, each of which was derived from an average of 30 speckle contrast maps.

### Quantification of measurement error due to user motion

Movement during LSCI can cause significant artifacts and measurement error. To quantify the effect of motion artifact imparted from using the LSCI-dermascope in a handheld fashion as opposed to mounted, LSCI measurements were acquired under these conditions from the tissue phantom used above. During handheld measurements, the LSCI-dermascope was held in direct contact with the tissue phantom for five seconds, during which 30 images were collected. Between measurements, the LSCI-dermascope was removed from the tissue phantom and then replaced. The same protocol was followed for mounted measurements but with the LSCI-dermascope rigidly mounted during image acquisition. For each condition, 10 measurements were acquired and averaged, each of which was derived from an average of 30 speckle contrast maps.

### Characterization of LSCI-dermascope measurements in a blood flow phantom

The response of the LSCI-dermascope to known fluid flow rates was characterized by acquiring data from a tissue phantom with an embedded tube to simulate a subsurface blood vessel which was located 0.5 mm below the surface. The phantom was fabricated from polydimethylsiloxane with titanium dioxide added to achieve a scattering coefficient of 1 mm−1 at 785 nm45,46. The embedded tube was made of Tygon and had an inner diameter of 0.79 mm. A syringe pump was used to flow lipid emulsion (Intralipid 20%, Fresenius Kabi, Toronto, Canada) at volumetric flow rates ranging from 0.01 to 0.09 mL/min. This range was chosen to simulate the approximate speed of blood flow in skin capillaries47. Intralipid was diluted to a concentration of 0.54% to result in a reduced scattering coefficient of 0.6 mm−1, which is comparable to that of human blood at 785 nm48,49,50,51. For each volumetric flow rate, the LSCI-dermascope was placed at the location shown in Fig. 3A and 30 images acquired. The average speckle contrast within 50 × 200 pixel region of each image corresponding to the area above the embedded tube (the dynamic region) and a 50 × 200 pixel region not above the embedded tube (the static region) was computed and averaged between all 30 frames.

### In vivo validation of LSCI-dermascope

To assess the LSCI-dermascope’s ability to differentiate quantitatively between skin lesions with suspected blood flow differences, LSCI data were acquired from 13 cherry angiomas and 10 solar lentigos. Cherry angiomas were expected to exhibit increased blood flow relative to the surrounding skin, whereas solar lentigos were not. Diagnosis of each lesion type was performed by a trained dermatologist (KMK) at the University of California, Irvine Health Gottschalk Medical Center. During LSCI measurements, the dermascope was placed over the lesion of interest and proper location confirmed visually using the magnified white-light image. Fifty images were acquired from each lesion. During processing, each image was converted to a SFI map and then averaged together. The median SFI was computed within a manually-selected region of interest corresponding to the lesion and the surrounding normal skin. A blood flow ratio was then computed for each lesion by dividing the median SFI in the lesion by the median SFI within the surrounding skin. The average of these ratios was computed for all cherry angiomas and for all solar lentigos. All human data collection was collected in accordance with methods approved by the University of California Institutional Review Board (HS#2008-6307). Informed consent was obtained from all subjects.

### Statistical Analysis

Statistical differences among populations were analyzed using either ANOVA or the Mann-Whitney test. p-values less than 0.05 were considered significant.

## Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

## References

1. 1.

Rosendahl, C. et al. Dermoscopy of squamous cell carcinoma and keratoacanthoma. Archives of Dermatology 148, 1386–1392, https://doi.org/10.1001/archdermatol.2012.2974 (2012).

2. 2.

Kapsokalyvas, D. et al. Imaging of human skin lesions with the multispectral dermoscope. Proceedings of the SPIE 7548, article 754808 (2010).

3. 3.

Malvehy, J., Braun, R. P., Puig, S., Marghoob, A. A. & Kopf, A. W. Handbook of dermoscopy. (CRC Press, 2006).

4. 4.

Eisemann, N. et al. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. Journal of Investigative Dermatology 134, 43–50 (2014).

5. 5.

Guy, G. P. Jr. & Ekwueme, D. U. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer. Pharmacoeconomics 29, 863–874 (2011).

6. 6.

Jemal, A. et al. Cancer statistics, 2008. CA: a cancer journal for clinicians 58, 71–96 (2008).

7. 7.

Argenziano, G. et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions: comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Archives of dermatology 134, 1563–1570 (1998).

8. 8.

Nachbar, F. et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. Journal of the American Academy of Dermatology 30, 551–559 (1994).

9. 9.

Stolz, W. et al. Abcd rule of dermatoscopy-a new practical method for early recognition of malignant-melanoma. European Journal of Dermatology 4, 521–527 (1994).

10. 10.

Lorentzen, H., Weismann, K., Secher, L., Sand Petersen, C. & Grønhøj Larsen, F. The dermatoscopic ABCD rule does not improve diagnostic accuracy of malignant melanoma. Acta dermatovenereologica-stockholm 79, 469–472 (1999).

11. 11.

Pizzichetta, M. A. et al. The ABCD rule of dermatoscopy does not apply to small melanocytic skin lesions. Archives of dermatology 137, 1376–1378 (2001).

12. 12.

Menzies, S. W. et al. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma. Archives of Dermatology 141, 1388–1396 (2005).

13. 13.

Anderson, R. Polarized light examination and photography of the skin. Archives of Dermatology 127, 1000–1005, https://doi.org/10.1001/archderm.1991.01680060074007 (1991).

14. 14.

de Roode, R., Noordmans, H. J., Rem, A., Couwenberg, S. & Verdaasdonk, R. Evaluation of laser treatment response of vascular skin disorders in relation to skin properties using multi-spectral imaging. 6842, 68420B-68420B-68429 (2008).

15. 15.

de Roode, R., Noordmans, H. J. & Verdaasdonk, R. Feasibility of multi-spectral imaging system to provide enhanced demarcation for skin tumor resection. 6424, 64240B-64240B-64248 (2007).

16. 16.

de Roode, R., Noordmans, H. J. & Verdaasdonk, R. Reproducible multispectral imaging in dermatology for diagnostics and treatment evaluation. 6078, 60780Q-60780Q-60789 (2006).

17. 17.

Noordmans, H. J., de Roode, R. & Verdaasdonk, R. Compact multi-spectral imaging system for dermatology and neurosurgery. 6510, 65100I-65100I-65108 (2007).

18. 18.

Moncrieff, M., Cotton, S., Claridge, E. & Hall, P. Spectrophotometric intracutaneous analysis: a new technique for imaging pigmented skin lesions. British Journal of Dermatology 146, 448–457 (2002).

19. 19.

Elbaum, M. et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. Journal of the American Academy of Dermatology 44, 207–218 (2001).

20. 20.

Jain, R. K. Determinants of tumor blood flow: a review. Cancer research 48, 2641–2658 (1988).

21. 21.

Vaupel, P., Kallinowski, F. & Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer research 49, 6449–6465 (1989).

22. 22.

Chin, C. W. S., Foss, A. J. E., Stevens, A. & Lowe, J. Differences in the vascular patterns of basal and squamous cell skin carcinomas explain their differences in clinical behaviour. The Journal of pathology 200, 308–313 (2003).

23. 23.

Enejder, A. M. K. et al. Blood perfusion studies on basal cell carcinomas in conjunction with photodynamic therapy and cryotherapy employing laser-Doppler perfusion imaging. Acta dermato-venereologica 80 (2000).

24. 24.

Stücker, M. et al. Blood flow compared in benign melanocytic naevi, malignant melanomas and basal cell carcinomas. Clinical and experimental dermatology 24, 107–111 (1999).

25. 25.

Zötterman, J., Mirdell, R., Horsten, S., Farnebo, S. & Tesselaar, E. Methodological concerns with laser speckle contrast imaging in clinical evaluation of microcirculation. PloS one 12, e0174703 (2017).

26. 26.

Duncan, D. D. & Kirkpatrick, S. J. Can laser speckle flowmetry be made a quantitative tool? JOSA A 25, 2088–2094 (2008).

27. 27.

Briers, D. et al. Laser speckle contrast imaging: theoretical and practical limitations. Journal of biomedical optics 18, 066018–066018 (2013).

28. 28.

Bandyopadhyay, R., Gittings, A. S., Suh, S. S., Dixon, P. K. & Durian, D. J. Speckle-visibility spectroscopy: A tool to study time-varying dynamics. Review of scientific instruments 76, 093110 (2005).

29. 29.

Beaconsfield, P. & Ginsburg, J. Effect of changes in limb posture on peripheral blood flow. Circulation research 3, 478–482 (1955).

30. 30.

Braverman, I. M. Ultrastructure and organization of the cutaneous microvasculature in normal and pathologic states. Journal of Investigative Dermatology 93, 2–9 (1989).

31. 31.

Braverman, I. M. & Keh-Yen, A. Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases. Journal of investigative dermatology 81, 489–497 (1983).

32. 32.

Mehregan, A. H. Lentigo senilis and its evolutions. Journal of Investigative Dermatology 65, 429–433 (1975).

33. 33.

Montagna, W., Hu, F. & Carlisle, K. A reinvestigation of solar lentigines. Archives of dermatology 116, 1151–1154 (1980).

34. 34.

Tur, E. & Brenner, S. Cutaneous blood flow measurements for the detection of malignancy in pigmented skin lesions. Dermatology 184, 8–11 (1992).

35. 35.

Ugnell, A. O. & Öberg, P. The optical properties of the cochlear bone. Medical engineering & physics 19, 630–636 (1997).

36. 36.

Kirkpatrick, S. J., Duncan, D. D. & Wells-Gray, E. M. Detrimental effects of speckle-pixel size matching in laser speckle contrast imaging. Optics letters 33, 2886–2888 (2008).

37. 37.

Boas, D. A. & Dunn, A. K. Laser speckle contrast imaging in biomedical optics. Journal of biomedical optics 15, 011109-011109–011112 (2010).

38. 38.

Briers, J. D. Laser speckle contrast imaging for measuring blood flow. Optica Applicata 37, 139 (2007).

39. 39.

Draijer, M., Hondebrink, E., van Leeuwen, T. & Steenbergen, W. Review of laser speckle contrast techniques for visualizing tissue perfusion. Lasers in medical science 24, 639–651 (2009).

40. 40.

Dunn, A. K., Bolay, H., Moskowitz, M. A. & Boas, D. A. Dynamic imaging of cerebral blood flow using laser speckle. Journal of Cerebral Blood Flow & Metabolism 21, 195–201 (2001).

41. 41.

Fercher, A. & Briers, J. Flow visualization by means of single-exposure speckle photography. Optics communications 37, 326–330 (1981).

42. 42.

Choi, B., Ramirez-San-Juan, J. C., Lotfi, J. & Nelson, J. S. Linear response range characterization and in vivo application of laser speckle imaging of blood flow dynamics. Journal of biomedical optics 11, 041129-041129–041127 (2006).

43. 43.

Ramirez-San-Juan, J. C., Ramos-Garcia, R., Guizar-Iturbide, I., Martinez-Niconoff, G. & Choi, B. Impact of velocity distribution assumption on simplified laser speckle imaging equation. Optics express 16, 3197–3203 (2008).

44. 44.

Yuan, S., Devor, A., Boas, D. A. & Dunn, A. K. Determination of optimal exposure time for imaging of blood flow changes with laser speckle contrast imaging. Applied optics 44, 1823–1830 (2005).

45. 45.

Ayers, F., Grant, A., Kuo, D., Cuccia, D. J. & Durkin, A. J. In Biomedical Optics (BiOS) 2008. 687007-687007-687009 (International Society for Optics and Photonics).

46. 46.

Boas, D. A., Pitris, C. & Ramanujam, N. Handbook of biomedical optics. (CRC press, 2011).

47. 47.

Fagrell, B., Fronek, A. & Intaglietta, M. A microscope-television system for studying flow velocity in human skin capillaries. American Journal of Physiology-Heart and Circulatory Physiology 233, H318–H321 (1977).

48. 48.

Driver, I., Feather, J. W., King, P. R. & Dawson, J. B. The optical properties of aqueous suspensions of Intralipid, a fat emulsion. Physics in medicine and biology 34, 1927 (1989).

49. 49.

Flock, S. T., Jacques, S. L., Wilson, B. C., Star, W. M. & van Gemert, M. J. C. Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers in surgery and medicine 12, 510–519 (1992).

50. 50.

Spinelli, L. et al. Determination of reference values for optical properties of liquid phantoms based on Intralipid and India ink. Biomedical optics express 5, 2037–2053 (2014).

51. 51.

Roggan, A., Friebel, M., Dörschel, K., Hahn, A. & Muller, G. Optical properties of circulating human blood in the wavelength range 400-2500 nm. Journal of biomedical optics 4, 36–46 (1999).

## Acknowledgements

The authors acknowledge institutional support from the Arnold and Mabel Beckman Foundation and funding in part from the National Institutes of Health (P41 EB015890, R01 DE022831) and the American Society for Laser Medicine and Surgery (research grant CS.F01.14). The authors would like to thank Mr. Ben Lertsakdadet and Dr. Caitlin Regan for their assistance with device development.

## Author information

S.M.W., B.C. and M.V. designed the experiments. S.M.W. performed the experiments with assistance of K.M.K. and M.V. K.M.K. and M.V. performed clinical assessments and diagnoses. S.M.W. analyzed experimental results. S.M.W. wrote the manuscript. All authors reviewed the manuscript.

Correspondence to Bernard Choi.

## Ethics declarations

### Competing Interests

The authors declare no competing interests.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## Rights and permissions

Reprints and Permissions

White, S.M., Valdebran, M., Kelly, K.M. et al. Simultaneous Blood Flow Measurement and Dermoscopy of Skin Lesions Using Dual-Mode Dermascope. Sci Rep 8, 16941 (2018). https://doi.org/10.1038/s41598-018-35107-x

• Accepted:

• Published: